4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-17-000281
EVP AND GC sold 26,365 shares at $39.66 ($1,045,517)
- EVP AND GC acquired 26,365 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baity Glenn EVP AND GC | 2017-02-14 | Option exercise | +20,000 | $8.32 | $166,400 | 87,063 | D |
| Baity Glenn EVP AND GC | 2017-02-14 | Option exercise | +6,365 | $1.64 | $10,439 | 93,428 | D |
| Baity Glenn EVP AND GC | 2017-02-14 | Sale | −26,365 | $39.66 | $1,045,517 | 67,063 | D |
| Derivatives | |||||||
| Baity Glenn EVP AND GC | 2017-02-14 | Option exercise · Stock Option (right to buy) | −16,776 | 0 | D | ||
| Baity Glenn EVP AND GC | 2017-02-14 | Option exercise · Stock Option (right to buy) | −3,224 | 0 | D | ||
| Baity Glenn EVP AND GC | 2017-02-14 | Option exercise · Stock Option (right to buy) | −6,365 | 0 | D | ||
| Open-market sales · 26,365 sh · avg $39.66 · $1,045,517 | |||||||
Loading xslF345X03/form4-02162017_040242.xml…